This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Moroxite I Ab, Seagles Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Deepak Bushan Raina: Innovator in Targeted Delivery of Bioactive Molecules
Introduction
Deepak Bushan Raina is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of medical treatments, particularly in the area of bacterial infections. His innovative approach focuses on the targeted delivery of bioactive molecules, which has the potential to improve treatment outcomes for patients.
Latest Patents
Deepak holds a patent for a treatment approach that involves the targeted delivery of bioactive molecules. This method includes administering a finely divided particulate material that is not bioresorbable or is very slowly bioresorbable. The treatment also incorporates a second material that is bioresorbable at a higher rate. This dual-material approach allows for a controlled release of pharmaceutically active compounds, which are essential for treating bacterial infections. His patent represents a significant advancement in the field of medical treatments.
Career Highlights
Throughout his career, Deepak has worked with various companies, including Moroxite AB and Moroxite T AB. His experience in these organizations has contributed to his expertise in the development of innovative treatment methods. Deepak's work has been recognized for its potential impact on healthcare and patient treatment strategies.
Collaborations
Deepak has collaborated with notable professionals in his field, including Magnus Tägil and Lars Åke Alvar Lidgren. These collaborations have further enhanced his research and development efforts, leading to advancements in targeted delivery systems for medical applications.
Conclusion
Deepak Bushan Raina is a pioneering inventor whose work in the targeted delivery of bioactive molecules is shaping the future of bacterial infection treatments. His innovative methods and collaborations highlight his commitment to advancing medical science.